DGI:ZNS-Infektionen/Tuberkulose Meningitis/Quellen: Unterschied zwischen den Versionen

← Zum vorherigen Versionsunterschied

Aktuelle Version vom 10. September 2026, 10:35 Uhr

Amagon KI et al., Methionine and vitamin B-complex ameliorate antitubercular drugs-induced toxicity in exposed patients. Pharmacol Res Perspect. 2017;5(5). doi:10.1002/prp2.360
Chin JH. Tuberculous meningitis: Diagnostic and therapeutic challenges. Neurol Clin Pract. 2014;4(3):199-205. doi:10.1212/CPJ.0000000000000023
Ducomble T et al., The burden of extrapulmonary and meningitis tuberculosis: an investigation of national surveillance data, Germany, 2002 to 2009. Euro Surveill. 2013;18(12):20436.
Marais S et al., Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis. 2010;10(11):803-812. doi:10.1016/S1473-3099(10)70138-9
National Collaborating Centre for Chronic Conditions (UK), Centre for Clinical Practice at NICE (UK). Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control. National Institute for Health and Clinical Excellence (UK); 2011. Accessed August 9, 2021. http://www.ncbi.nlm.nih.gov/books/NBK97852/
Prasad K et al., Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2016;4:CD002244. doi:10.1002/14651858.CD002244.pub4
Schaberg T et al., [Tuberculosis Guideline for Adults - Guideline for Diagnosis and Treatment of Tuberculosis including LTBI Testing and Treatment of the German Central Committee (DZK) and the German Respiratory Society (DGP)]. Pneumologie. 2017;71(6):325-397. doi:10.1055/s-0043-105954
Thwaites GE et al., Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004;351(17):1741-1751. doi:10.1056/NEJMoa040573
Thwaites G et al., British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect. 2009;59(3):167-187. doi:10.1016/j.jinf.2009.06.011
Wilkinson RJ et al., Tuberculous meningitis. Nat Rev Neurol. 2017;13(10):581-598. doi:10.1038/nrneurol.2017.120
Lange C et al. , Update: Therapie der medikamentenresistenten Tuberkulose (DR-TB) in Deutschland, Österreich und der Schweiz – Aktualisierte Empfehlungen auf Basis der WHO-Leitlinien 2025. Pneumologie 2026; 80: 160–167. https://doi.org/10.1055/a-2731-0729
AWMF-Leitlinie: https://register.awmf.org/assets/guidelines/020-019l_S2k_Tuberkulose-im-Erwachsenenalter_2023-09.pdf

@@ Zeile 1: / Zeile 1: @@
-== Quellen ==
+* Amagon KI et al., Methionine and vitamin B-complex ameliorate antitubercular drugs-induced toxicity in exposed patients. Pharmacol Res Perspect. 2017;5(5). doi:10.1002/prp2.360
-. <span style="box-sizing: inherit;">       </span> Schaberg T, et al., Tuberculosis Guideline for Adults - Guideline for Diagnosis and Treatment of Tuberculosis including LTBI Testing and Treatment of the German Central Committee (DZK) and the German Respiratory Society (DGP). Pneumologie 2017; '''71'''(6): 325-397
+* Chin JH. Tuberculous meningitis: Diagnostic and therapeutic challenges. Neurol Clin Pract. 2014;4(3):199-205. doi:10.1212/CPJ.0000000000000023
+* Ducomble T et al., The burden of extrapulmonary and meningitis tuberculosis: an investigation of national surveillance data, Germany, 2002 to 2009. Euro Surveill. 2013;18(12):20436.
-. <span style="box-sizing: inherit;">       </span> Wilkinson RJ, et al., Tuberculous meningitis''.'' Nat Rev Neurol, 2017; '''13'''(10): 581-598
+* Marais S et al., Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis. 2010;10(11):803-812. doi:10.1016/S1473-3099(10)70138-9
+* National Collaborating Centre for Chronic Conditions (UK), Centre for Clinical Practice at NICE (UK). Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control. National Institute for Health and Clinical Excellence (UK); 2011. Accessed August 9, 2021. <nowiki>http://www.ncbi.nlm.nih.gov/books/NBK97852/</nowiki>
-. <span style="box-sizing: inherit;">       </span> Ducomble T, et al., The burden of extrapulmonary and meningitis tuberculosis: an investigation of national surveillance data, Germany, 2002 to 2009. Euro Surveill, 2013; '''18'''(12)
+* Prasad K et al., Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2016;4:CD002244. doi:10.1002/14651858.CD002244.pub4
+* Schaberg T et al., [Tuberculosis Guideline for Adults - Guideline for Diagnosis and Treatment of Tuberculosis including LTBI Testing and Treatment of the German Central Committee (DZK) and the German Respiratory Society (DGP)]. Pneumologie. 2017;71(6):325-397. doi:10.1055/s-0043-105954
-. <span style="box-sizing: inherit;">       </span> in Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control. 2011; London
+* Thwaites GE et al., Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004;351(17):1741-1751. doi:10.1056/NEJMoa040573
+* Thwaites G et al., British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect. 2009;59(3):167-187. doi:10.1016/j.jinf.2009.06.011
-. <span style="box-sizing: inherit;">       </span> Thwaites G, et al., British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect, 2009; '''59'''(3): 167-87
+* Wilkinson RJ et al., Tuberculous meningitis. Nat Rev Neurol. 2017;13(10):581-598. doi:10.1038/nrneurol.2017.120
+* Lange C et al. , Update: Therapie der medikamentenresistenten Tuberkulose (DR-TB) in Deutschland, Österreich und der Schweiz – Aktualisierte Empfehlungen auf Basis der WHO-Leitlinien 2025. Pneumologie 2026; 80: 160–167. https://doi.org/10.1055/a-2731-0729
-. <span style="box-sizing: inherit;">       </span> Marais S, et al., Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome. Clin Infect Dis, 2013; '''56'''(3): 450-60
+* AWMF-Leitlinie: https://register.awmf.org/assets/guidelines/020-019l_S2k_Tuberkulose-im-Erwachsenenalter_2023-09.pdf
-. <span style="box-sizing: inherit;">       </span> Chin JH, Tuberculous meningitis: Diagnostic and therapeutic challenges. Neurol Clin Pract, 2014; '''4'''(3):199-205
-. <span style="box-sizing: inherit;">       </span> Marais S, et al., Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis, 2010; '''10'''(11): 803-12
-. <span style="box-sizing: inherit;">       </span> Amagon KI, Awodele O and Akindele AJ, Methionine and vitamin B-complex ameliorate antitubercular drugs-induced toxicity in exposed patients. Pharmacol Res Perspect, 2017; '''5'''(5)
-. <span style="box-sizing: inherit;">     </span> Prasad K and Singh MB, Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev, 2008(1); CD002244
-. <span style="box-sizing: inherit;">     </span> Thwaites GE, et al., Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med, 2004; '''351'''(17): 1741-51